Postoperative course of body weight.

<p>Points represent average relative body weight, in relation to the weight prior to operation, for the control group (□) and the groups receiving tacrolimus: T0.5 (◼), T2 (Δ) and T5 (●).</p

Wound hydroxyproline content.

<p>Data are expressed as hydroxyproline content per 5 mm tissue length and represent mean and SEM for the controls (white bars) and the T2 (grey bars) and T5 (black bars) tacrolimus groups. A= ileum, B= colon, C = fascia. *: p<0.05 vs T2 group; #: p<0.05 vs control group.</p

MMP activity in intestinal anastomoses.

<p>Columns represent mean values + SEM for controls (white bars) and the T2 (grey bars) and T5 (black bars) tacrolimus groups. Data represent total activities, in arbitrary units, per 5-mm segment for proMMP-9 (A), MMP-9 (B), proMMP-2 (C), and MMP-2 (D). *: p<0.05 vs control group.</p

Wound breaking strength.

<p>Data represent mean and SEM in the control groups (white bars) and the T0.5 (black & white bars), T2 (grey bars) and T5 (black bars) tacrolimus groups. A= ileum anastomoses, B= colon anastomoses, C = fascia.</p

Effect of IPC on serum creatinine after renal IRI.

<p>Left side favours control (renal IRI only), right side favours IPC. An overall beneficial effect of IPC on serum creatinine was observed (1.54 [1.16, 1.93]). Data presented as SMD and 95% CI.</p

Flow chart of study selection.

<p>The number of studies in each phase is indicated between brackets.</p

Effect of IPC on BUN after renal IRI.

<p>Left side favours control (renal IRI only), right side favours IPC. An overall beneficial effect of IPC on BUN was observed (1.42 [0.97, 1.87]). Data presented as SMD and 95% CI.</p